Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants
NCT ID: NCT03237715
Last Updated: 2017-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2017-07-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific Aim 2: Measure Bf levels in breast fed and formula fed infants and examine their relationship to unbound fatty acid (FFAu) levels.
Specific Aim 3: To demonstrate that phototherapy results in different changes in TSB and Bf.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
NCT02691156
BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator
NCT03942757
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
NCT03195998
Prediction of Neonatal Hyperbilirubinemia
NCT01109277
The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants
NCT01762189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast fed cohort
Assessment of unbound bilirubin levels
Collection of residual blood for measurement of unbound bilirubin
Formula fed cohort
Assessment of unbound bilirubin levels
Collection of residual blood for measurement of unbound bilirubin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of unbound bilirubin levels
Collection of residual blood for measurement of unbound bilirubin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Hours
7 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Hegyi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.